Can patients slow AFib-RVR at home? Milestone enrolls first patient in pivotal ReVeRA-301
ReVeRA-301 will test self-administered etripamil in about 150 patients, using ventricular-rate reduction within 30 minutes as the primary endpoint and the same regimen already approved for PSVT.